“Vascular response to everolimus- and biolimus-eluting coronary stents versus everolimus-eluting bioresorbable scaffolds – an optical coherence tomography substudy of the EVERBIO II trial” (2016) Swiss Medical Weekly, 146(0102), p. w14274. doi:10.4414/smw.2016.14274.